Benzinga | Aug 11, 2020 04:30PM EDT

Aridis Pharmaceuticals Q2 EPS $(0.47) Up From $(1.03) YoY, Sales $1.00K

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.47) per share. This is a 54.37 percent increase over losses of $(1.03) per share from the same period last year. The company reported $1.00 thousand in sales this quarter.